|
Volumn 111, Issue 1071, 1998, Pages 285-287
|
Lipid-modifying drugs
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CHOLESTEROL;
COLESTYRAMINE;
FLUINDOSTATIN;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN;
PRAVASTATIN;
SIMVASTATIN;
CHOLESTEROL BLOOD LEVEL;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
HUMAN;
HYPERCHOLESTEROLEMIA;
ISCHEMIC HEART DISEASE;
LIPID BLOOD LEVEL;
LIVER TOXICITY;
MYOSITIS;
RISK FACTOR;
ANTILIPEMIC AGENTS;
CLINICAL TRIALS;
DRUG UTILIZATION;
HUMANS;
LEGISLATION, DRUG;
NEW ZEALAND;
|
EID: 0032516754
PISSN: 00288446
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (3)
|
References (27)
|